Literature DB >> 24353900

Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy.

Lalit P Singh1.   

Abstract

Chronic hyperglycemia (HG)-associated reactive oxygen/nitrogen species (ROS/RNS) stress and low grade inflammation are considered to play critical roles in the development of diabetic retinopathy (DR). Excess glucose metabolic flux through the aldose reductase/polyol pathway, advanced glycation end product (AGE) formation, elevated hexosamine biosynthesis pathway (HBP), diacyl glycerol/PKC activation, and mitochondrial ROS generation are all implicated in DR. In addition, endoplasmic reticulum stress/unfolded protein response (er-UPR) and deregulation of mitochondrial quality control by autophagy/mitophagy are observed causing cellular bioenergetic deficiency and injury. Recently, a pro-oxidant and pro-apoptotic thioredoxin interacting protein (TXNIP) was shown to be highly upregulated in DR and by HG in retinal cells in culture. TXNIP binds to thioredoxin (Trx) inhibiting its oxidant scavenging and thiolreducing capacity. Hence, prolonged overexpression of TXNIP causes ROS/RNS stress, mitochondrial dysfunction, inflammation and premature cell death in DR. Initially, DR was considered as microvascular complications of endothelial dysfunction and pericyte loss characterized by capillary basement membrane thickening, pericyte ghost, blood retinal barrier leakage, acellular capillary and neovascularization. However, it is currently acknowledged that neuro-glia are also affected by HG in diabetes and that neuronal injury, glial activation, innate immunity/sterile inflammation, and ganglion apoptosis occur early in DR. In addition, retinal pigment epithelium (RPE) becomes dysfunctional in DR. Since TXNIP is induced by HG in most cells, its effects are not restricted to a particular cell type in DR. However, depending on the metabolic activity and anti-oxidant capacity, some cells may be affected earlier by TXNIP than others. Identification of TXNIP sensitive cells and elucidating the underlying mechanism(s) will be critical for preventing pre-mature cell death and progression of DR.

Entities:  

Keywords:  Inflammation; Mitochondrial dysfunction; Premature cell death; ROS/RNS stress; TXNIP

Year:  2013        PMID: 24353900      PMCID: PMC3864179          DOI: 10.4172/2155-9570.1000287

Source DB:  PubMed          Journal:  J Clin Exp Ophthalmol


  179 in total

1.  Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis.

Authors:  Z Wang; Y P Rong; M H Malone; M C Davis; F Zhong; C W Distelhorst
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

2.  Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).

Authors:  Huan Yang; Peter Lundbäck; Lars Ottosson; Helena Erlandsson-Harris; Emilie Venereau; Marco E Bianchi; Yousef Al-Abed; Ulf Andersson; Kevin J Tracey; Daniel J Antoine
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

3.  Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.

Authors:  Chae Young Hwang; Yeung Sook Ryu; Mi-Sun Chung; Kwang Dong Kim; Sung Sup Park; Suhn-Kee Chae; Ho Zoon Chae; Ki-Sun Kwon
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

4.  Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells.

Authors:  Mohammed A Abdelsaid; Suraporn Matragoon; Azza B El-Remessy
Journal:  Antioxid Redox Signal       Date:  2013-07-12       Impact factor: 8.401

5.  Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells.

Authors:  Weiqin Chen; Donald B Jump; Maria B Grant; Walter J Esselman; Julia V Busik
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

6.  High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.

Authors:  Elodie Masson; Shlomit Koren; Fathima Razik; Howard Goldberg; Edwin P Kwan; Laura Sheu; Herbert Y Gaisano; I George Fantus
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-17       Impact factor: 4.310

7.  Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells.

Authors:  Tsutomu Kobayashi; Sayuri Uehara; Takanori Ikeda; Hiraku Itadani; Hidehito Kotani
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

8.  Connexin immunoreactivity in glial cells of the rat retina.

Authors:  Kathleen R Zahs; Paulo Kofuji; Carola Meier; Rolf Dermietzel
Journal:  J Comp Neurol       Date:  2003-01-20       Impact factor: 3.215

9.  An isoform of retinoid-related orphan receptor β directs differentiation of retinal amacrine and horizontal interneurons.

Authors:  Hong Liu; Soo-Young Kim; Yulong Fu; Xuefeng Wu; Lily Ng; Anand Swaroop; Douglas Forrest
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Thioredoxin interacting protein is a potential regulator of glucose and energy homeostasis in endogenous Cushing's syndrome.

Authors:  Tove Lekva; Jens Bollerslev; Afaf Sahraoui; Hanne Scholz; Hege Bøyum; Johan Arild Evang; Kristin Godang; Pål Aukrust; Thor Ueland
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more
  44 in total

1.  Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.

Authors:  Zhuo Chen; Feng Miao; Andrew D Paterson; John M Lachin; Lingxiao Zhang; Dustin E Schones; Xiwei Wu; Jinhui Wang; Joshua D Tompkins; Saul Genuth; Barbara H Braffett; Arthur D Riggs; Rama Natarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 2.  Understanding Metabolic Memory: A Tale of Two Studies.

Authors:  Rachel G Miller; Trevor J Orchard
Journal:  Diabetes       Date:  2020-03       Impact factor: 9.461

Review 3.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

4.  Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein.

Authors:  Zhiliang He; Youjia Yu; Yunhong Nong; Lingyao Du; Cong Liu; Yong Cao; Lang Bai; Hong Tang
Journal:  Oncol Lett       Date:  2017-06-01       Impact factor: 2.967

5.  Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression.

Authors:  Priya Pradhan; Nisha Upadhyay; Archana Tiwari; Lalit P Singh
Journal:  New Front Ophthalmol       Date:  2016-10-24

6.  Thioredoxin-Interacting Protein (TXNIP) Regulates Parkin/PINK1-mediated Mitophagy in Dopaminergic Neurons Under High-glucose Conditions: Implications for Molecular Links Between Parkinson's Disease and Diabetes.

Authors:  Cun-Jin Su; Zhu Shen; Ru-Xiao Cui; Ya Huang; De-Lai Xu; Feng-Lun Zhao; Jie Pan; Ai-Ming Shi; Tong Liu; Yun-Li Yu
Journal:  Neurosci Bull       Date:  2020-01-14       Impact factor: 5.203

7.  Deletion of the stress-response protein REDD1 promotes ceramide-induced retinal cell death and JNK activation.

Authors:  Weiwei Dai; William P Miller; Allyson L Toro; Adam J Black; Sadie K Dierschke; Robert P Feehan; Scot R Kimball; Michael D Dennis
Journal:  FASEB J       Date:  2018-06-19       Impact factor: 5.191

Review 8.  Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit.

Authors:  Islam N Mohamed; Tauheed Ishrat; Susan C Fagan; Azza B El-Remessy
Journal:  Antioxid Redox Signal       Date:  2014-11-11       Impact factor: 8.401

Review 9.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 10.  Promoting Neuronal Tolerance of Diabetic Stress: Modulating Molecular Chaperones.

Authors:  S M Emery; R T Dobrowsky
Journal:  Int Rev Neurobiol       Date:  2016-04-05       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.